News
Ann-Kathrin’s Vpr paper is published in Cell Reports, April 2022


Ann-Kathrin’s paper showing how HIV-1 uses its Vpr to reprogram resting T cells to adopt a tissue-resident like phenotype is out now in Cell Reports.
'Evolution of enhanced innate immune evasion by SARS-CoV-2' is published in Nature, Dec 2021


Lucy and AK's work with Lorena and Mehdi Bouhaddou from the Krogen Lab on the enhanced evasion of the inante immune system by the Alpha varient when compared to the first wave strains is published in Nature.
Clare and Nevan spoke with Nature news about our recent Biorxiv paper on adaption of B1.1.7 to evade innate immunity, June 2021


...
'Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant' is on BioRxiv and The New York Times has published an article on it, June 2021


Our latest paper demonstrating our work on how the Alpha variant evades early immune responses is on BioRxiv and it has attracted the attention of the New York Times.
Tafhima's paper 'HIV envelope tail truncation confers resistance to SERINC5 restriction' is out in PNAS, May 2021


ABC News joined AK and Lucy as they met with Lorena and the rest of our American collaborators on Teams, March 2021


HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells is out on BioRxiv! Jan 2021

'Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant published' on BioRxiv, Jan 2021


The first study of the full-length B.1.1.7 variant virus, we find two host-directed drugs to possess similar antiviral activity against both the early-lineage SARS-CoV-2 and the B.1.1.7 variant. Read the results of AK, Lucy and Lorena's long hours and hard work alongside the Krogan lab at UCSF.
AK, Lucy, Lorena and Matt's paper is published on the BioRxiv preprint server, Dec 2020


All the hours and hard work in the cat3 lab have paid off. AK, Lucy, Lorena, and Matt's paper is published on the BioRxiv server. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation.
Our collaborative work is publlished in Leukemia, March 2020

'SARS-CoV-2 antibody responses in patients with aggressive haematological malignancies' Jenny O'Nions, Luke Muir, Jiexin Zheng, Chloe Rees-Spear, Annachiara Rosa, Christopher Earl, Peter Cherepanov, Rajeev Gupta, Asim Khwaja, Clare Jolly, Laura E McCoy
The Jolly lab has re-opened for SARS-CoV-2 work, April 2020

We are working closely with the Towers, Selwood and Noursadeghi labs (UCL) to address the following questions:
· How does the virus trigger innate and proinflammatory responses across different cell types in vitro?
· Which pathways lead to proinflammatory cytokine secretion and cell death, as observed in severe COVID-19 patients?
· How do the responses observed in vitro compare to those seen in vivo?
· How do the innate responses influence immune crosstalk and T cell functions associated with immunopathology in severe COVID-19 patients?
· Can we identify specific pathways and inhibitors to modulate innate and immune crosstalk to reduce pro-inflammatory responses and cell death?
· Which viral proteins activate or antagonise innate responses?
· Which restriction factors target SARS-CoV-2 and do these contribute to innate immune signalling?
We have been busy supporting the work of other groups at UCL by getting our CL3 labs operational for SARS-CoV-2, and training and supervising new users:


Dejan's paper is published in Proceedings of the National Academy of Sciences of the United States of America, March 2020
Mesner D, Hotter D, Kirchhoff F, Jolly C. Loss of Nef-mediated CD3 down-regulation in the HIV-1 lineage increases viral infectivity and spread. Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7382-7391. doi: 10.1073/pnas.1921135117. Epub 2020 Mar 16.
Clare presented at the 1st Max Planck Society Workshop on HIV Reservoirs and Evolution in St Lucia, South Africa. January 2019


Clare presented on 'Cell - Cell spread of HIV-1' and rounded the conference off with a safari with Greg, Ravi, and Laura.
Infection and Immunity's Christmas Party, December 2018

Jolly Lab Retreat in Amsterdam with the Towers Lab, December 2018

.

We attended the Frontiers of Retrovirology conference in Leuven, Belgium, September 2018.

Jolly Lab win at the Feathers pub quiz, 2018

The Lab was at the the 10th Blizard Institute HIV Symposium, June 2018
Setting up the draw for the department World Cup sweepstake, 2018
The department was swept up in World Cup fever thanks to an ingenious system devised by the Jolly lab of countries written on agar. You have to grow your bacteria to see who you drew!
Microbiology Society Conference, 2018

Infection and Immunity divisional Christmas Party, December 2017

Christmas celebrations with the Towers lab at 'Watch Me', December 2017

WOHL Christmas Dinner, December 2017

Halloween celebrations with the Towers lab, October 2017
Halloween dressing up - a character that shares your initails......
Towers lab picnic in Regent's Park, August 2017

Our Latest Paper is Published in Cell Reports, 2017.

Infection and Immunity Christmas Party, December 2016
Looking good at Infection and Immunity's Christmas party.
WOHL Christmas dinner, 2016

Dr Shimona Stirling leaves the Jolly lab, 2016

Towers lab picnic in Regents Park, August 2016

Two generations of HIV scientists meet, 2016

Shimona Starling wins 1st prize at the Colloquium, 2015

Clare Secures a further 5 years funding, 2015

Celebrations were held in the UCL Quad to congratulate Clare along with Dr Joe Grove, Prof Greg Towers and Dr Ravi Gupta who all secured Wellcome Trust grants.
Clare's Image on the cover of Journal of Virology, Jan 2015

Elisabetta Spent 6 weeks in Sierra Leone, Feb 2015

.